Evidence map›Paper›PMID 33790990›Full record

ArticlePolymer chemistry2020

Pro-organic radical contrast agents ("pro-ORCAs") for real-time MRI of pro-drug activation in biological systems.

Hung V-T Nguyen, Alexandre Detappe, Peter Harvey, Nolan Gallagher, Clelia Mathieu, Michael P Agius, Oksana Zavidij, Wencong Wang, Yivan Jiang, Andrzej Rajca and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Polymer chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Generalizable Strategies for the Synthesis of Cereblon-Recruiting PROTAC Prodrugs.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. HACS omega · 2026
    Article
  6. Article
  7. Fluorinated Human Serum Albumin as PotentialMolecules (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Review
  10. Precise Synthesis and Thin Film Self-Assembly of PLLA-Molecules (Basel, Switzerland) · 2021
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Hung V-T Nguyen *Department of Chemistry, Massachusetts Institute of Technology (MIT).
Alexandre Detappe *David H. Koch Institute for Integrative Cancer Research, MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Peter HarveyDepartment of Biological Engineering, MIT.
Nolan GallagherDepartment of Chemistry, Massachusetts Institute of Technology (MIT).
Clelia MathieuDepartment of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Michael P AgiusDepartment of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Oksana ZavidijDepartment of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
Wencong WangDepartment of Chemistry, Massachusetts Institute of Technology (MIT).
Yivan JiangDepartment of Chemistry, Massachusetts Institute of Technology (MIT).
Andrzej RajcaDepartment of Chemistry, University of Nebraska, Lincoln, Nebraska 68588, United States.
Alan JasanoffDepartment of Biological Engineering, MIT.
Irene M GhobrialDepartment of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, United States.
P Peter GhoroghchianDavid H. Koch Institute for Integrative Cancer Research, MIT, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
Jeremiah A JohnsonDepartment of Chemistry, Massachusetts Institute of Technology (MIT).
Harvard University · USMassachusetts Institute of Technology · USMoscow Institute of Thermal Technology · RUAllen Institute · USUniversity of Nebraska–Lincoln · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Paula T Hammond · 1985 to 2026
$93.9M
Organic nanoparticles for dual MRI-guided therapeutic selection and ovarian cancer drug deliveryR01CA220468 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jeremiah Allen Johnson · 2017 to 2026
$4.9M
Calcium sensors for molecular fMRIU01NS090451 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JASANOFF, ALAN · 2014 to 2016
$1.1M
NCI NIH HHS P30 CA014051NCI NIH HHS R01 CA220468NINDS NIH HHS U01 NS090451Wellcome Trust
6 · The paper itself

Abstract

Nitroxide-based organic-radical contrast agents (ORCAs) are promising as safe, next-generation magnetic resonance imaging (MRI) tools. Nevertheless, stimuli-responsive ORCAs that enable MRI monitoring of prodrug activation have not been reported; such systems could open new avenues for prodrug validation and image-guided drug delivery. Here, we introduce a novel "pro-ORCA" concept that addresses this challenge. By covalent conjugation of nitroxides and drug molecules (doxorubicin, DOX) to the same brush-arm star polymer (BASP) through chemically identical cleavable linkers, we demonstrate that pro-ORCA and prodrug activation,

Identifiers

PMID33790990
PMCPMC8009311
OpenAlexW3037420235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.